Spots Global Cancer Trial Database for CBCT-Guided Navigational Bronchoscopy For Lung Nodules

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: CBCT-Guided Navigational Bronchoscopy For Lung Nodules

Official Title: Cone Beam Computed Tomography - Guided Navigation Bronchoscopy for Peripheral Pulmonary Nodules: A Randomized Trial

Study ID: NCT04758403

Conditions

Peripheral Pulmonary Nodules

Lung; Node

Cone Beam Computed Tomography

Guided Navigation Bronchoscopy

Interventions

Navigation Bronchoscopy

Cone beam computed tomography (CBCT)

Study Description

Brief Summary: The purpose of this study is to determine if the cone beam computed tomography (CBCT)-guided navigation bronchoscopy is better in diagnosing lung nodules compared to navigation bronchoscopy alone.

Detailed Description: This clinical trial examines the effectiveness of a treatment comparing it to another known treatment. The U.S. Food and Drug Administration (FDA) has approved the navigation bronchoscopy as a treatment option for this disease. The U.S. Food and Drug Administration (FDA) has approved the Cone-Beam CT scan as a treatment option for this disease. This research study involves a screening period, a procedure and follow up visits. The names of the study interventions involved in this study are: * Computed tomography (CBCT)-guided navigation bronchoscopy (CBCT-guided NB) * Navigation bronchoscopy alone Participants will receive the study procedure and will be followed for up to 6 months. It is expected that about 136 people will take part in this research study.